RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Provision for income taxes

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Dec 31, 20243-35.33%
Dec 31, 20235+0.00%
Dec 31, 20225-62.87%
Dec 31, 202113+316.48%
Dec 31, 20203+33.88%
Dec 31, 20192+0.00%
Dec 31, 20182+0.00%
Dec 31, 20172-123.92%
Dec 31, 2016-10-601.09%
Dec 31, 20152+7377.78%
Dec 31, 20140

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)